Tech Company Financing Transactions

Cannabco Pharmaceutical Funding Round

Cannabco Pharmaceutical secured a $24 million funding round on 5/9/2017. Backers included private investors.

Transaction Overview

Announced On
5/9/2017
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the funds to build out of two production facilities located in the Greater Toronto Area (GTA) as well as operating capital to fund its initial crop productions.

Company Information

Company Status
Private & Independent
Industry
AgTech
Mailing Address
Undisclosed
Toronto ON, M4C 5K7
Canada
Email Address
Overview
Cannabco is dedicated to establishing itself as a leader in affordable Medical Marijuana supply and research contributing to the growing needs of Canadians. At this time Cannabco is in the process of applying to become a Licensed Producer (LP) under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
Profile
Cannabco Pharmaceutical LinkedIn Company Profile
Social Media
Cannabco Pharmaceutical Company Twitter Account
Company News
Cannabco Pharmaceutical News
Facebook
Cannabco Pharmaceutical on Facebook
YouTube
Cannabco Pharmaceutical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Pellicane
  Mark Pellicane LinkedIn Profile  Mark Pellicane Twitter Account  Mark Pellicane News  Mark Pellicane on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/9/2017: Kobalt venture capital transaction
Next: 5/9/2017: SimpleReach venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary